KS

Kottangoden Sahir

Active Director Director DIN 11412143
DIN 11412143 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kottangoden Sahir

Data last updated:

Kottangoden Sahir is a Director at Nuvora Health Care Private Limited (since 2025).

DIN 11412143
Primary Designation Director
First Appointment 06 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nuvora Health Care Private Limited U21001KL2025PTC098937
Director06 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Nuvora Health Care Private Limited
Premium access

Shareholding and investment profile for Kottangoden Sahir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kottangoden Sahir

Kottangoden Sahir currently holds 1 directorship: Nuvora Health Care Private Limited (Director, since 06 Dec 2025).

Kottangoden Sahir was first appointed on 06 Dec 2025 as Director at Nuvora Health Care Private Limited.

The current boards of Kottangoden Sahir's companies include Adil Ummer Karadan (Nuvora Health Care Private Limited), Choolakkaparambu Aboobakker Anwar Sadath (Nuvora Health Care Private Limited), Muhsin (Nuvora Health Care Private Limited), Neelambra Ajmal Nazir (Nuvora Health Care Private Limited), Rahiman Panattakayil Abdul Nassar (Nuvora Health Care Private Limited), Wazeem Kadengal (Nuvora Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available